Jefferson Parker

Jacksonville College — United States

Medicine · Health Sciences

5h-index400citations12works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(7), Chronic Lymphocytic Leukemia Research(3), Lung Cancer Treatments and Mutations(2), Health Systems, Economic Evaluations, Quality of Life(2), CAR-T cell therapy research(2)

Publications12 total

Outcomes of Concomitant Autoimmune Diseases in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies
Transplantation and Cellular Therapy·2026
POSTER: ABCL-817 Real-World Outcomes of Frontline Polatuzumab and Impact of Frailty in Older Adults With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): A Multicenter Study
Clinical Lymphoma Myeloma & Leukemia·2025
ABCL-817: Real-World Outcomes of Frontline Polatuzumab and Impact of Frailty in Older Adults With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): A Multicenter Study
Clinical Lymphoma Myeloma & Leukemia·2025
Fimepinostat (CUDC‐907) in patients with relapsed/refractory diffuse large B cell and high‐grade B‐cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses
British Journal of Haematology·2021· 43 citedOpen Access
Correlation of MYC gene signature variations with clinical response to fimepinostat in patients with aggressive B-cell lymphoma.
Journal of Clinical Oncology·2020
Preclinical Activity of IRAK4 Kinase Inhibitor CA-4948 Alone or in Combination with Targeted Therapies and Preliminary Phase 1 Clinical Results in Non-Hodgkin Lymphoma
Blood·2018· 10 cited
CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial
Haematologica·2017· 130 citedOpen Access
Contents Vol. 133, 2015
Acta Haematologica·2015Open Access
Yttrium-90 Ibritumomab Tiuxetan Followed by Rituximab Maintenance as Treatment for Patients with Diffuse Large B-Cell Lymphoma Are Not Candidates for Autologous Stem Cell Transplant
Acta Haematologica·2015· 11 cited
Therapeutic Implications of Diffuse Hepatic Uptake after Iodine-131 Therapy for Differentiated Thyroid Cancer
2011
Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study.
Journal of Clinical Oncology·1996· 205 cited
Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma
Journal of Clinical Oncology·1996· 1 cited

Frequent Co-authors

M Krámer(2), Augustinus D. G. Krol(2), Hanneke C. Kluin‐Nelemans(2), H. L. Haak(2), K. van Groningen(2), J. Han van Krieken(2), Yasuhiro Oki(2), Kevin R. Kelly(2), David Tuck(2), Anas Younes(2), Jon Arnason(2), Katarina Luptakova(2), Jacalyn Rosenblatt(2), Dimitrios Tzachanis(2), David Avigan(2), Jeffrey I. Zwicker(2), James D. Levine(2), Barbara Grant(2), Robin Joyce(2), Jessica Chicola(2)